My Top 3 Biotech Stocks Report Next Week (I Actually Now Have A 4th Subscribers Already Positioned In That Play) And We Have No Position In AMGN!
But let's see how these suggested plays from 09/03/09 play out this week! Keep in mind all our options are 2010 expiration option plays. So just in case we have a market wiggle we gave ourself enough time to bounce back.
How to Double Your Money on 3 Top Biotech Stocks
Not too many sectors can claim that they made new all-time highs after the worst bear market that most of us can remember just a few short months after the broader market bottomed.
So, while many market pundits continue to call for a stock market correction as we enter what is historically the worst month of the year for the stock market, I offer three trades in the biotech sector.
The higher stocks in general go, the louder the predictions for disaster will be. But before we circle the months of September and October on our End of Days calendar, let's take a look at Celgene Corp. (CELG), Gilead Sciences (GILD) and Amgen (AMGN) as biotech plays that should continue the move the Amex Biotechnology Index (BTK).
First, let's review the BTK. As you can see from the chart below, it has broken out from an ascending triangle to new all-time highs.
